Increased risks of venous thromboembolism in patients with psoriasis

Summary

Systemic inflammation and hypercoagulability in psoriasis are related to cardiovascular morbidity. The aim of the study was to investigate the incidence and risk of venous thromboembolism (VTE) in patients with psoriasis in Taiwan. We identified inpatients aged ≥ 18 years with a diagnosis of psoriasis and controls at a 1: 1 ratio of frequency matched by sex, age, frequency of medical visits, length of stay, and comorbidities between 2000 and 2010 in the Taiwan National Health Insurance Research Database. Each patient was traced to the date of VTE occurrence, loss to follow-up, death, or the December 31, 2011, whichever occurred first. We analysed 8945 patients with psoriasis and 8945 controls. The patients with psoriasis exhibited a greater incidence rate of VTE (19.2 vs 9.88 per 10 000 person-years) than did the controls. After adjustment for covariates, the patients with psoriasis presented a 2.02-fold risk of VTE (adjusted hazard ratio [aHR] = 2.02, 95% confidence interval [CI] = 1.42–2.88) compared with that in the control cohort. The aHR of VTE was significantly higher in the first year of follow-up (aHR = 3.30, 95% CI = 1.45–7.55) than after one year (aHR = 1.68, 95% CI = 1.13–2.49).

Keywords

Psoriasis - venous thromboembolism (VTE) - cohort study

• References

• 1 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 23 Suppl 1 I4-8.
• 2 Cushman M, Tsai AW, White RH. et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25.
• 3 Sun Y, Chen D, Xu Z. et al. Incidence of symptomatic and asymptomatic venous thromboembolism after elective knee arthroscopic surgery: a retrospective study with routinely applied venography. Arthroscopy 2014; 30: 818-822.
• 4 Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med 2013; 126 832 e13-21.
• 5 Naess IA, Christiansen SC, Romundstad P. et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 05: 692-699.
• 6 Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev 2009; 23: 225-229.
• 7 Anderson Jr. FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 23 Suppl 1 I9-16.
• 8 Chung WS, Lin CL, Chang SN. et al. Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with spinal cord injury: a nationwide cohort prospective study. Thromb Res 2014; 133: 579-584.
• 9 Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 2005; 94: 362-365.
• 10 Chung WS, Lin CL, Peng CL. et al. Rheumatoid arthritis and risk of acute myocardial infarction--a nationwide retrospective cohort study. Internat J Cardiol 2013; 168: 4750-4754.
• 11 Chung WS, Peng CL, Lin CL. et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis 2014; 73: 1774-1780.
• 12 Chung WS, Lin CL, Chang SN, Lu CC, Kao CH. Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study. J Thromb Haemost 2014; 12: 452-458.
• 13 Chung WS, Lin CL, Sung FC. et al. Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Rheumatology 2014; 53: 1639-1645.
• 14 Chung WS, Lin CL, Sung FC. et al. Increased risks of deep vein thrombosis and pulmonary embolism in Sjogren syndrome: a nationwide cohort study. J Rheumatol 2014; 41: 909-915.
• 15 Chung WS, Lin CL, Sung FC. et al. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study. Thromb Res 2014; 134: 622-626.
• 16 Tamagawa-Mineoka R, Katoh N, Kishimoto S. Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin. J Am Acad Dermatol 2010; 62: 621-626.
• 17 Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
• 18 Ramagopalan SV, Wotton CJ, Handel AE. et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011; 09: 1
• 19 Ahlehoff O, Gislason GH, Lindhardsen J. et al. Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PloS one 2011; 06: e18125.
• 20 Lutsey PL, Prizment AE, Folsom AR. Psoriasis is associated with a greater risk of incident venous thromboembolism: the Iowa Women's Health Study. J Thromb Haemost 2012; 10: 708-711.
• 21 NHIA. National Health Insurance Annual Report 2014–2015. Taipei: Taiwan: National 291 Health Insurance Administration, Ministry of Health and Welfare. Taiwan, R. O.C: 292 2015. 2015.
• 22 Chang YT, Chen TJ, Liu PC. et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol 2009; 89: 262-266.
• 23 Ungprasert P, Sanguankeo A, Upala S, Suksaranjit P. Psoriasis and risk of venous thromboembolism: a systematic review and meta-analysis. QJM 2014; 107: 793-797.
• 24 Lee CH, Lin LJ, Cheng CL. et al. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost 2010; 08: 1515-1523.
• 25 Brezinski EA, Follansbee MR, Armstrong EJ, Armstrong AW. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Curr Pharmaceut Des 2014; 20: 513-528.
• 26 Steyers 3rd CM, Miller Jr. FJ. Endothelial dysfunction in chronic inflammatory diseases. Internat J Mol Sci 2014; 15: 11324-11349.
• 27 Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscl Thromb Vasc Biol 2003; 23: 168-175.
• 28 Migliacci R, Becattini C, Pesavento R. et al. Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 2007; 92: 812-818.
• 29 Mazzoccoli G, Fontana A, Grilli M. et al. Idiopathic deep venous thrombosis and arterial endothelial dysfunction in the elderly. Age 2012; 34: 751-760.
• 30 Tsai TF, Wang TS, Hung ST. et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci 2011; 63: 40-46.
• 31 Davidovici BB, Sattar N, Prinz J. et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-1796.
• 32 Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131: 417-430.
• 33 Kasperska-Zajac A, Brzoza Z, Rogala B. Platelet function in cutaneous diseases. Platelets 2008; 19: 317-321.
• 34 Kawada A, Tezuka T, Nakamizo Y. et al. A survey of psoriasis patients in Japan from 1982 to 2001. J Dermatol Sci 2003; 31: 59-64.
• 35 Queiro R, Tejon P, Coto P. et al. Clinical differences between men and women with psoriatic arthritis: relevance of the analysis of genes and polymorphisms in the major histocompatibility complex region and of the age at onset of psoriasis. Clin Develop Immunol 2013; 2013: 482691.
• 36 Eder L, Thavaneswaran A, Chandran V, Gladman DD. Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Ann Rheum Dis 2013; 72: 578-582.
• 37 Chang CM, Liao SC, Chiang HC. et al. Gender differences in healthcare service utilisation 1 year before suicide: national record linkage study. Br J Psych 2009; 195: 459-460.
• 38 Chung WS, Lin CL, Kao CH. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Thromb Haemost 2015; 114: 812-818.
• 39 Sun LM, Chung WS, Lin CL, Liang JA, Kao CH. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study. J Thromb Haemost 2016; 14: 495-503.
• 40 Chung WS, Lin CL, Ho FM. et al. Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J 2014; 43: 801-807.
• 41 Dean SM, Abraham W. Venous thromboembolic disease in congestive heart failure. Congest Heart Fail 2010; 16: 164-169.